Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. - Wikidata - awgldk - TriplyDB

Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers.

Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers.

http://www.wikidata.org/entity/Q34043681

about

Genome-edited human stem cell-derived beta cells: a powerful tool for drilling down on type 2 diabetes GWAS biology Recent Advances in Genome Editing Using CRISPR/Cas9 CRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseases Spermatogonial stem cell autotransplantation and germline genomic editing: a future cure for spermatogenic failure and prevention of transmission of genomic diseases An Overview of CRISPR-Based Tools and Their Improvements: New Opportunities in Understanding Plant-Pathogen Interactions for Better Crop Protection Next generation sequencing technology and genomewide data analysis: Perspectives for retinal research Genome Engineering with TALE and CRISPR Systems in Neuroscience Neurogenethics: An emerging discipline at the intersection of ethics, neuroscience, and genomics Understanding Spatial Genome Organization: Methods and Insights Nuclease Target Site Selection for Maximizing On-target Activity and Minimizing Off-target Effects in Genome Editing Advanced In vivo Use of CRISPR/Cas9 and Anti-sense DNA Inhibition for Gene Manipulation in the Brain Making sense of GWAS: using epigenomics and genome engineering to understand the functional relevance of SNPs in non-coding regions of the human genome Beyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogation Applications of CRISPR-Cas systems in neuroscience How specific is CRISPR/Cas9 really?Diversity of CRISPR-Cas immune systems and molecular machines Epigenetic marks: regulators of livestock phenotypes and conceivable sources of missing variation in livestock improvement programs Applications of Engineered DNA-Binding Molecules Such as TAL Proteins and the CRISPR/Cas System in Biology Research Enabling functional genomics with genome engineering Strategies for precision modulation of gene expression by epigenome editing: an overview Genomic Views of Transcriptional Enhancers: Essential Determinants of Cellular Identity and Activity-Dependent Responses in the CNS The complexity of epigenetic diseases The New State of the Art: Cas9 for Gene Activation and Repression Use of designer nucleases for targeted gene and genome editing in plants Genome-editing tools for stem cell biology Chromatin Dynamics in Lineage Commitment and Cellular Reprogramming The CRISPR revolution and its impact on cancer research Recent advances on Candida albicans biology and virulence The epigenome: the next substrate for engineering CRISPR-Cas: biology, mechanisms and relevance CRISPR-Mediated Epigenome Editing Editing the Neuronal Genome: a CRISPR View of Chromatin Regulation in Neuronal Development, Function, and Plasticity Biotechnology and apple breeding in Japan CRISPR-Cas9: Tool for Qualitative and Quantitative Plant Genome Editing Epigenetic Editing: On the Verge of Reprogramming Gene Expression at Will Epigenetic Control of Smooth Muscle Cell Identity and Lineage Memory The CRISPR system can correct or modify the expression of genes responsible for hereditary diseases Exploiting the CRISPR/Cas9 PAM Constraint for Single-Nucleotide Resolution Interventions CHOPCHOP v2: a web tool for the next generation of CRISPR genome engineering Ligand-binding domains of nuclear receptors facilitate tight control of split CRISPR activity

P2860

Q26742051-682CCEAA-0051-4E62-8105-023C2DE094C2 Q26744073-33B29898-AEB5-4A76-9B63-AFBD48264A89 Q26744172-A399658E-68EA-4AAA-9957-94209FCE5277 Q26744780-D00CD794-1883-4D97-A3E3-22D8FCB16800 Q26745534-2A8BCEDF-0C02-4CE6-9B33-C27BA347E314 Q26746206-E3CAF32E-9F92-4FC3-B956-E00D37203DB6 Q26752488-375DFB75-B733-489F-98A7-2E460C1FD40A Q26764827-ABEACEFD-2AD8-4D03-A09D-72D5EA031040 Q26766143-D0265A75-ACBD-445E-B3F1-B57664EFA633 Q26770012-F27B3A04-7F54-4A65-9A07-8199893E5AF4 Q26770355-5473F3F3-079B-4DA0-B18A-B7CE2FFF5AE6 Q26771497-94302C8A-A018-4F3D-9CD5-6948CD9AE115 Q26775746-ACF9141B-8645-4440-B244-744CAD3ED4A7 Q26776515-A1B88598-8F0E-4AF4-B0F8-7AD10B82E05C Q26777801-30ED7C07-12AA-4486-A2D0-1544827E12CA Q26778564-3689CE71-45D0-42A5-ADD3-0270C5563ABE Q26781132-FDE76442-8C8A-4969-9AAC-88A0618F2803 Q26781399-51AF0D35-05D4-40F4-8488-E71EB3652F9A Q26782747-C12EE16A-22CA-45AB-8533-134B2B2F71ED Q26782876-1E0410EF-B58F-42C2-9FE2-B225BFA7E9DC Q26782959-C32C5E00-4537-4A74-A4DF-84E6B5962FE6 Q26784416-F264A29C-91CB-4DFA-A073-27C329D1568F Q26787037-3F787F10-E149-453E-8393-6E9FC96E8219 Q26799592-63D729EA-B6AC-4C9E-9705-6052AE17342D Q26800186-771909A3-B463-4A70-9B21-B023378FD60A Q26801740-94AA7790-F1E1-4AA5-8CBD-14BB86856B3E Q26824997-4422B824-E32D-4134-B3D2-12B8AEF5B248 Q28066567-9B909F68-6DB9-481E-B1F4-F856492097A2 Q28068278-92D7AD33-3FFD-44AC-82B3-B14FA133A398 Q28069426-A6C5FDC8-54F0-4256-A0A2-A0B4B6B51301 Q28075872-C1CBBD00-1F70-4106-A878-72A4A12ABE4B Q28075883-ED6D30F6-3984-4E5B-B01B-9F6916B04EE9 Q28079047-AE261547-4868-4978-B553-C526977001F7 Q28079519-C50D168E-207C-4630-A15B-3D502EF2E15F Q28080188-6B4B4D84-61E0-4F9F-ACF5-8FB1ABEF8804 Q28085153-0AC4E9DC-B825-4D32-BDF7-45A60023756C Q28085767-56741C53-EB21-44CE-9D81-3822658E625A Q28552692-4E45DF4B-B134-4D38-A4C5-2862F54AE277 Q28830073-8BB18279-6A42-40F9-A411-AF25D93BAFD8 Q28831343-6F10121D-551A-45D7-B2A6-20F4F0B16978

P2860

Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers.

http://www.wikidata.org/entity/Q34043681

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Epigenome editing by a CRISPR- ...... from promoters and enhancers.

@ast

Epigenome editing by a CRISPR- ...... from promoters and enhancers.

@en

Epigenome editing by a CRISPR- ...... from promoters and enhancers.

@nl

type

label

Epigenome editing by a CRISPR- ...... from promoters and enhancers.

@ast

Epigenome editing by a CRISPR- ...... from promoters and enhancers.

@en

Epigenome editing by a CRISPR- ...... from promoters and enhancers.

@nl

prefLabel

Epigenome editing by a CRISPR- ...... from promoters and enhancers.

@ast

Epigenome editing by a CRISPR- ...... from promoters and enhancers.

@en

Epigenome editing by a CRISPR- ...... from promoters and enhancers.

@nl

P1433

Q34043681-C112A5CA-7C24-4243-B518-5100B27FBA2C

P1476

Q34043681-C11E9D17-EB2E-4DBF-83DC-4E78F0222718

P2093

Q34043681-15FD10ED-61B3-4067-AB6C-ACE5D00355AE

Q34043681-31FFFD98-D008-4742-AC49-B9C9CA717CAF

Q34043681-68D2A8C4-BFF9-4C4A-B1F1-94D97FB3C1F7

Q34043681-AF79BD39-74B7-4D5A-9A70-0787BB7E32EB

Q34043681-CFF580D6-9A4A-477E-BFF2-D90640A14E67

P2860

Q34043681-0CAEAD9F-80B1-4F4B-B996-55D5869B6AC1

Q34043681-1250A0C9-DE5A-4F1C-9911-BE376A032646

Q34043681-16C7BD55-EE16-4E70-8D9E-E2EE0155D9CF

Q34043681-1BDFB173-5FF5-4F66-BBCC-EC2D1CC8BA19

Q34043681-1EF8A007-BD61-43AA-B9D2-485099C02DFA

Q34043681-261023CC-91FE-4110-BF69-D9972C29EAB6

Q34043681-2D807AF6-1B60-4E86-AD93-6057DED05976

Q34043681-3281F9CE-6FB9-4B8F-AFBE-CC098EBB63C9

Q34043681-33901755-E5A7-4A24-BE9C-0B532C8110FF

Q34043681-45EEE59B-6F52-41D0-945A-792C60974BB1

P2888

Q34043681-EABF2EDB-F183-442E-8CE9-66570FEE8490

P304

Q34043681-5168523D-96CB-43B3-AA7B-E6AF787FC5DA

P31

Q34043681-F17646E8-34BB-4D91-9EAF-A6D8A98F9DF3

P356

Q34043681-A20C8861-6B92-4546-A010-EE5A194837AD

P433

Q34043681-8F56BBB5-F9AC-44A8-8E1E-C4675C85CBD0

P478

Q34043681-A2D91D85-2A3A-470F-A7CE-A91532062622

P50

Q34043681-B014AE24-7FDB-4890-A754-572F00497EE6

Q34043681-EE271C0E-E0DE-4ECE-8C03-B688F40A491E

P577

Q34043681-7D7FB99A-7FE3-4F0C-AD36-B249A8ADF97B

P5875

Q34043681-AFACB963-A44B-4CAC-8C87-E07372C3DE77

P698

Q34043681-186CC470-37A1-46BE-9374-1A18E79EDED3

P921

Q34043681-B806B48D-77FA-4A73-A7B4-759C5A6DE7EC

P932

Q34043681-5F1525DD-CDF1-42E7-8AAD-CC9DEDE32A7A

P356

P1433

Nature Biotechnology

P1476

Epigenome editing by a CRISPR- ...... s from promoters and enhancers

@en

P2093

Anthony M D'Ippolito

http://www.w3.org/2001/XMLSchema#string

Charles A Gersbach

http://www.w3.org/2001/XMLSchema#string

Christopher M Vockley

http://www.w3.org/2001/XMLSchema#string

Gregory E Crawford

http://www.w3.org/2001/XMLSchema#string

Pratiksha I Thakore

http://www.w3.org/2001/XMLSchema#string

P2860

An integrated encyclopedia of DNA elements in the human genome

RNA-guided human genome engineering via Cas9

Tunable and multifunctional eukaryotic transcription factors based on CRISPR/Cas

Multiplex genome engineering using CRISPR/Cas systems

CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes

Positive and negative regulation of endogenous genes by designed transcription factors

A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity

Structure of the p300 catalytic core and implications for chromatin targeting and HAT regulation

Fast gapped-read alignment with Bowtie 2

The transcriptional coactivators p300 and CBP are histone acetyltransferases

P2888

P304

510-517

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NBT.3199

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

Timothy E Reddy

P577

2015-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274643363

http://www.w3.org/2001/XMLSchema#string

P698

25849900

http://www.w3.org/2001/XMLSchema#string

P921

P932

4430400

http://www.w3.org/2001/XMLSchema#string